Dr Gregor Will, medical practitioner, Cologne
OCCURRENCE AND DIAGNOSIS OF MILDEW FUNGI CONTAMINATION
Serious gaps in our knowledge still exist with regard to the importance of diagnosing and treating fungal illnesses in practices and hospitals (Mycology Study Group at the Robert Koch Institute in Berlin, WHO). Not only candida, but also mildew fungi infections play an increasingly important role in causing chronic illnesses. Sources of mildew fungi are wherever dampness, earth and rotting substances are. This is especially true of leaves, waste, compost, garden earth, animal pens, and in general also of all plants.
The air contains large amounts of fungi in the months with humid, changeable weather (in Europe) like February, March, April, September, October and November. In these months, dry winds which spread spores are often followed by humid weather with considerable fungal increase. Some fungi are able to release up to 20 million spores per minute. This is several times the amount of pollen present in air.
Typical sources of mildew fungi in buildings are mildew spots on walls, furniture, carpets, curtains, at the back of wooden facing, on tiled walls in damp areas (kitchen, bathroom, cellar), at the wastepipes of basins and showers, as well as on mattresses and upholstered furniture. Flower containers and humidifiers, especially in air conditioners, are also dangerous. Certain food groups are often contaminated with mildew fungi. This is especially true of nuts, seeds, fats, milk, spices, meat and meat products, sugar, sweets, bread, cakes and pastries as well as of fruit and vegetables.
But the most important (and growing) problem is the use of fungal cultures as socalled starterswithin the framework of biotechnology and gene technology. Even experts no longer have an overview of the increasing number and types of industrially used enzymes (enzymes on a mildew fungi base). These substances cause symptoms similar to those of food allergies in people sensitive to mildew fungi. In addition these enzymes are also used in the production of consumer goods like toothpaste, mouthwash, skincare products, detergents as well as textile, leather and fur products.
The most common enzyme producers are aspergillus, cladosporium, rhizopus and mucor types, which can all form toxins. Aflatoxin is the best known, and is known to be carcinogenic.
Apart from absorbing mildew fungi substances through food and air, the danger of being exposed to mildew fungi products in medication is very high. In medication of plant origin or teas, residue or metabolic products from naturally occurring mildew fungi attacks on the whole plant or on residues may be present. In addition, countless medications (e. g. contrast media, local anaestethics, cortisone preparations, antiallergic medication (!), gastrointestinal medication, homione preparations, etc.) contain either direct metabolic products of fungi (antibiotics) or mildew fungi enzymes as effective and/or ancillary substances (e. g. corrective substances, stabilisers or fillers. Many medications taken orally contain citric acid as a taste enhancer. This is almost without exception produced by aspergillus niger. Mildew fungi are also used in the chemical synthesis of vitamins.
Proving the presence of mildew fungi and/or their toxins is very easy to do bioenergetically with the „ident” reaction of the tensor. Schumacher’s ampoules or those in the mucosa test set from the Cross linked Test Technique according to Keymer may be used. Often the ampoules „Aspergillus Mix” (especially aspergillus niger) and „Aflatox in” test positively. In the case of the so called „ intramural” (inside of walls) mildew fungi, the am poule „Mucor Mix” often tests positively, and in the case of the „extramural” (outside walls) mildew fungi, the ampoules „Alternaria tenuis” and „Cladosporium Mix” often indicate a contamina tion.
Aflatoxin, which is often present, will be discussed in detail. Several researchers have already confirmed that up to 60 % of all foods are contaminated by mildew fungi. Within the past 36 months, 70 % of my bioresonance therapy patients were positively tested for mildew fungi and 35 % for aflatoxin contamination.
In the case of aflatoxin, we have one of the strongest natural carcinogens known today.
I believe contamination by mildew fungi increases in importance within the framework of the diagnosis and therapy of multicausally contaminated patients with impaired excretory organs. This is because of the increasing distribution of mildew fungi and their high biochemical and biophysical pathogenici
Especially in the case of allergic illnesses, the presence of mildew fungi contamination (toxins and allergy component) should be considered. The listing of 248 patients contaminated by mildewfungi (table 1) substantiates the often increased presence in different clinical pictures:
- Of the 248 patients
- 154 62.1 % are contaminated with aspergillus niger
- 127 51.2 % are contaminated with aflatoxin.
Apart from the frighteningly high incidence of mildew fungi contamination, the seriousness of the course of the disease must be emphasised. Often several different mildew fungi contaminations (i. a. aspergillus, aflatoxin, mucor) can be proven, especially in the case of the course of the disease becoming increasingly serious, with therapy resistant asthma syndrome or with patients suffering from urticaria and even immune vasculitis. These patients, in particular, profit from biophysical therapy measures after exact biophysical diagnosis.
BIOPHYSICAL THERAPY OF MILDEW FUNGI CONTAMINATION
Especially during toxin removal, a restriction period should be observed as far as possible. The patients should avoid nuts, blue cheese, coffee, wine and champagne. Medication taken alongside the toxin removal therapy must be tested regularly for mildew fungi contamination and if necessary the accompanying medication therapy should be changed. Of course, the criteria of the Therapeutic.
House should be fulfilled BICOM optima®lly. The basis of all treatment with bioresonance therapy is the activation of the excretory organs. Specific excretion of the tested mildew fungi contamination may follow only when all excretory organs are open. It cannot be emphasised enough that orthomolecular BICOM® resonance therapy and/or substitution therapy should accompany excretion, especially in the case of aflatoxin.
The individual steps in the bioenergetic therapy of mildew fungi contamination are listed in table 2.
Especially in the case of mildew fungi, intensification of the biophysical therapy measures is often possible by:
- 1.Additional output applicators on the symptom zones.
- 2.Native allergen in the input cup.
- 3.Testing of the BICOM optima®l therapy type Ai or Di.
- 4.Testing of the BICOM optima®l frequency.
- 5.Testing of the necessary therapy time per amplification level.
- 6.Gradual level increase or decrease with tested time per level.
- 7.Keeping in mind further allergy programmes
- 8.Putting oil and drops in the output cup.
- 9.Microbiological and orthomolecular suppor ting therapy via programme 192 and/or substitution.
- 10.Using the body’s own substances, especially sputum and anal swabs.
Using the new functions of the BICOM® 2000 instrument is an additional valuable way of intensifying treatment. By using BICOM® 2000, it is possible to biophysically adapt BICOM optima®lly to the specific metabolic situation of each patient, especially those who are multifactorially contaminated by aggressiveoxic reactions of a single burden (e.g.mildew fungi). Depending on his energetic state one can either stabilise or damp down the patient. The additional use of these BiCom 2000 elements enables one to reduce excretory reactions, shorten the treatment and reduce the number of therapy failures.
IMP RESSIVE NEW THERAPY METHODS WITH Wm/ 2000
Especially in the case of serious chronic clinical pictures it is possible with BICOM® 2000 to get the patients into a more stable regulatory state within a shorter time. The following facts about the treatment of mildew fungi contamination may be emphasised:
1.By adding dampingdown dynamic multiimpulse bundles (DMI), acute symptoms like pruritus, rhinoconjunctivitis and asthma are regulated fast. Some patients even report a clear clinical improvement during treatment itself.
2.The additional use of buildingup DMI bundles brings chronically tired patients with multiple organ contamination to a balanced regulatory state faster. Mycotic contamination can be stabilised in about 25 % fewer therapy sessions than with traditional BicOM therapy.
3.The transformation of BICOM® oscillations into ma gnetic frequency patterns (BMF) causes faster activation of toxins in patients contaminated with mycoses. This is connected to a feeling of warmth or relaxation as well as an obectively faster and more stable activation of the excretory organs.
Mildew fungi contamination play an increasingly important role in multifactorially contaminated patients because of the numerous possibilities for exposure. Adapting a citation of Prof. Rieth, th e Nestor of mycology, it is true that „only those who think of mildew fungi will find them”. Through the different bioenergetic test and treatment methods it is possible to diagnose clinical pictures according to their causes and to remove the corresponding contamination permanently. BICOM® 2000 is a valuable addition to these treatment methods for beginners and advanced users.